首页> 外国专利> VINBLASTINE 20' AMIDES: SYNTHETIC ANALOGS THAT MAINTAIN OR IMPROVE POTENCY AND SIMULTANEOUSLY OVERCOME Pgp-DERIVED EFFLUX AND RESISTANCE

VINBLASTINE 20' AMIDES: SYNTHETIC ANALOGS THAT MAINTAIN OR IMPROVE POTENCY AND SIMULTANEOUSLY OVERCOME Pgp-DERIVED EFFLUX AND RESISTANCE

机译:VINBLASTINE 20'酰胺:合成模拟物,可维持或提高电位并同时克服Pgp引起的流出和电阻

摘要

A vinca alkaloid compound substituted at the 20′-position with a carboxamido group is disclosed. The carbonyl of the carboxamido group is bonded to a 20′-amino group and to a ring system that contains up to three 5-, 6- or 7-membered rings that are fused or otherwise bonded together. Each ring can be carbocyclic or heterocyclic, with a heterocyclic ring containing up to three hetero ring atoms that are the same or different and are selected from nitrogen, oxygen and sulfur. The ring system can include up to four substituent groups other than hydrogen that are discussed within. Methods of preparing the compounds are disclosed as are compositions for their use and methods of treatment using d compound. A particularly preferred compound has an activity in specified cancer cell growth inhibition assays that is the same or better than its parental, unsubstituted vinca compound and is not subject to Pgp-mediated efflux.
机译:公开了在20'-位被羧酰胺基取代的长春花生物碱化合物。羧酰胺基的羰基键合至20'-氨基和环系统,该环系统包含最多三个稠合或以其他方式键合的5、6或7元环。每个环可以是碳环或杂环,其中杂环含有至多三个相同或不同并且选自氮,氧和硫的杂环原子。环系统可包含除氢以外的多达四个取代基。公开了制备化合物的方法以及其用途的组合物和使用d化合物的治疗方法。特别优选的化合物在特定的癌细胞生长抑制试验中具有与其母体未取代的长春花化合物相同或更好的活性,并且不经受Pgp介导的外排。

著录项

  • 公开/公告号US2019119277A1

    专利类型

  • 公开/公告日2019-04-25

    原文格式PDF

  • 申请/专利权人 THE SCRIPPS RESEARCH INSTITUTE;

    申请/专利号US201816052307

  • 发明设计人 DALE BOGER;

    申请日2018-08-01

  • 分类号C07D471/22;A61P35;A61P35/02;

  • 国家 US

  • 入库时间 2022-08-21 12:08:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号